


Poster: Tumor homology with self as a biomarker for response to checkpoint inhibitor therapy
EpiVaxTx_SITC22_Melanoma_28Oct22_56Wx31.5H
Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy

Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models
Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models